GSK GSK plc
$50.94▼ -0.31%
Healthcare
Other
After hours
$50.94▲ +0.00%
Oct 27, 5:27 PM ET
Volume 4.70M
Avg Volume (10D) 5.16M
Key Metrics & Fundamentals
Market Cap
$102.06B
P/E Ratio
16.1
Div Yield
3.55%
52W Range
42.89 - 61.70
% vs 50 MA
2.67%
% vs 200 MA
-2.72%
RSI-14
60.2
MACD Histogram
+0.4600
Beta (1Y vs SPY)
0.22
Free Cash Flow
$2.04B
Gross Rev
$8.41B
Gross Profit
$6.14B
EBITDA
$2.83B
COGS
$2.27B
Operating Exp
$5.66B
Operating Income
$481.00M
EBIT
$481.00M
Pretax Income
$354.00M
Net Income
$435.00M
EPS (Diluted)
0.21
Price & Volume History
Loading chart…
Recent News
GSK Showcases Strong Oncology Pipeline Data at ESMO Investor Update
MarketBeat · Oct 27, 2026 2:04 PM ET
Gilead to Report Q3 Earnings: How Should You Play the Stock Now?
Zacks · Oct 27, 2026 10:50 AM ET
What Could GSK (LSE:GSK) Oncology Progress Mean For Investors?
Simply Wall St. · Oct 27, 2026 5:08 AM ET
Can Specialty Meds Offset GSK’s $2.2B Legal Charges and Sizzling R&D Setbacks on Oct. 28?
24/7 Wall St. · Oct 24, 2026 11:08 AM ET
GSK (LSE:GSK) Secures Ex China Rights To KRAS EGFR Cancer Drug
Simply Wall St. · Oct 23, 2026 3:15 AM ET
How First In Class Hepatitis B Approval At GSK (LSE:GSK) Has Changed Its Investment Story
Simply Wall St. · Oct 23, 2026 12:33 AM ET
GSK (LSE:GSK) Stock May Trade At A Discount Despite Hibsago Approval
Simply Wall St. · Oct 22, 2026 11:19 PM ET
Why GSK Rose Even Though Profit Fell
Simply Wall St. · Oct 22, 2026 10:15 PM ET
Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks · Oct 22, 2026 9:00 AM ET
Can Expanding Ivonescimab Development Unlock SMMT's Growth Potential?
Zacks · Oct 21, 2026 10:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See GSK's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.